KUALA LUMPUR: Covid-19 patients who took Ivermectin were more likely to get diarrhoea, says Datuk Dr Noor Azmi Ghazali.
The Deputy Health Minister I said the ministry's clinical trials concluded that other than giving patients an upset stomach, there were no significant differences between those given Ivermectin and those treated using Covid-19 standard care treatment.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!